OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-derived xenograft models in cancer therapy: technologies and applications
Yihan Liu, Wantao Wu, Changjing Cai, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 435-442
Closed Access | Times Cited: 22

SERS in 3D cell models: a powerful tool in cancer research
Lara Troncoso-Afonso, Gail A. Vinnacombe‐Willson, Clara García‐Astrain, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 5118-5148
Open Access | Times Cited: 12

Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1

ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer
Li‐Ping Ge, Xi Jin, Ding Ma, et al.
Cell Research (2024) Vol. 34, Iss. 1, pp. 58-75
Closed Access | Times Cited: 10

Recent advances in breast cancer cell line research
Manika P Sharma, Supriya Shukla, Gauri Misra
International Journal of Cancer (2024) Vol. 154, Iss. 10, pp. 1683-1693
Closed Access | Times Cited: 7

Targeting HER3 to overcome EGFR TKI resistance in NSCLC
Qiuqiang Chen, Gang Jia, Xilin Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6

Discovering Tumor Microenvironment Dynamics in HPV-Associated Cancers: Using Organoid-Based Models to Develop Therapeutics
Babak Arjmand, Ghazal Najafi, Sepideh Alavi-Moghadam, et al.
Regenerative Engineering and Translational Medicine (2025)
Closed Access

Investigating proteogenomic divergence in patient-derived xenograft models of ovarian cancer
Jesenia M. Perez, Jolene M. Duda, Joohyun Ryu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Technological advances in clinical individualized medication for cancer therapy: from genes to whole organism
Jiejing Kai, Xueling Liu, Meijia Wu, et al.
Personalized Medicine (2025), pp. 1-14
Open Access

SILK FIBROIN-COATED MESOPOROUS SILICA NANOPARTICLES ENHANCE 6-THIOGUANINE DELIVERY AND CYTOTOXICITY IN BREAST CANCER CELLS
MOHAMMAD AMIN KABOLI, Alaa A. Hashim, Dhiya Altememy, et al.
International Journal of Applied Pharmaceutics (2025), pp. 275-283
Open Access

Optimizing Xenograft Models for Breast Cancer: A Comparative Analysis of Cell-Derived and Patient-Derived Implantation Techniques in Pre-Clinical Research
Astrid Feinisa Khairani, Shella Harmonia, Yoan Chou, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 1-10
Open Access

The importance of preclinical models for cholangiocarcinoma drug discovery
Florian Primavesi, Felix J. Krendl, Rupert Oberhuber, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access

Advances and Challenges in Human 3D Solid Tumor Models
Naveen Natesh, Shyni Varghese
Advanced Functional Materials (2025)
Closed Access

Nanoparticle-Mediated mRNA Delivery to Triple-Negative Breast Cancer (TNBC) Patient-Derived Xenograft (PDX) Tumors
Sara El‐Sahli, Shireesha Manturthi, Emma Durocher, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access

Patient-derived xenograft models of gastrointestinal stromal tumors: a ready-to-use platform for translational research
Luna De Sutter, Lore De Cock, Chao‐Chi Wang, et al.
Disease Models & Mechanisms (2025)
Open Access

Differences in treatment outcome between translational platforms in developing therapies for gastrointestinal cancers.
Katarzyna Wawrzak-Pienkowska, Tomasz Pienkowski, Anna Tankiewicz‐Kwedlo, et al.
European Journal of Pharmacology (2025), pp. 177309-177309
Closed Access

Breast cancer and its genetic heterogeneity at single cell level: A concise perspective of cellular architecture and taxonomy
Riya Sharma, Neha Parihar, Keerti Gopi, et al.
Elsevier eBooks (2025), pp. 89-112
Closed Access

Methods for Preclinical Assessment of the Efficacy of Anticancer Medicines in vivo (Review)
M. L. Vasyutina, Kirill V. Lepik, Maria S. Istomina, et al.
Regulâtornye issledovaniâ i èkspertiza lekarstvennyh sredstv. (2025)
Open Access

Basic Science, New Target Investigation, and Research in Childhood Cancer
Hafeez Abdelhafeez, Victor M. Santana
(2025), pp. 1-6
Closed Access

Recent Advancement in Breast Cancer Research: Insights from Model Organisms—Mouse Models to Zebrafish
Sharad S. Singhal, Rachana Garg, Atish Mohanty, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2961-2961
Open Access | Times Cited: 15

Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research
Weijing Wang, Li Y, Kaida Lin, et al.
Animal Models and Experimental Medicine (2023) Vol. 6, Iss. 5, pp. 381-398
Open Access | Times Cited: 14

Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top